CD19 and cervical carcinoma: Next, we used qRT-PCR analysis to validate the correlation between TCL1A and CD19+ B cells and improved survival in cervical cancer patients by analyzing the expression levels of CD19, CD20 and TCL1A in fresh-frozen cervical cancer samples obtained from 15 patients in the same cohort and an additional 37 samples.